Docoh
Loading...

Andrew Schiermeier

Andrew Schiermeier is EVP, Chief Operating Officer of Intellia Therapeutics Inc.

Person profile

Roles
Intellia Therapeutics EVP, Chief Operating Officer
Address
Cambridge, Massachusetts
Employees
SEC CIK

Calendar

21 Jan 22
Date Company Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
3 Mar 21 NTLA Intellia Therapeutics RSU Common Stock Grant Acquire A No No 0 13,125 0 13,125
3 Mar 21 NTLA Intellia Therapeutics Stock Option Common Stock Grant Acquire A No No 57.71 78,750 4.54M 78,750
5 Jan 21 NTLA Intellia Therapeutics Common Stock Sell Dispose S No No 55.86 1,377 76.92K 16,656
31 Dec 20 NTLA Intellia Therapeutics Common Stock Option exercise Acquire M No No 0 4,792 0 18,033
31 Dec 20 NTLA Intellia Therapeutics RSU Common Stock Option exercise Dispose M No No 0 4,792 0 0
31 Dec 20 NTLA Intellia Therapeutics RSU Common Stock Grant Acquire A No No 0 4,792 0 4,792
31 Dec 20 NTLA Intellia Therapeutics Stock Option Common Stock Grant Acquire A No No 20.56 9,583 197.03K 9,583
30 Dec 20 NTLA Intellia Therapeutics Common Stock Option exercise Acquire M No No 13.48 1,500 20.22K 12,673
30 Dec 20 NTLA Intellia Therapeutics Stock Option Common Stock Option exercise Dispose M No No 13.48 1,500 20.22K 148,500

Financial reports

No filings

Current reports

No filings

Registration and prospectus

No filings

Proxies

No filings

Other

No filings